Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-08-01

FDA Approved: NURTEC ODT — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

The FDA approved Pfizer's supplemental application for Nurtec ODT (rimegepant sulfate). The approval updates/expands the product's labeling and/or indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NURTEC ODT (RIMEGEPANT SULFATE)

Snippet

SUPPL AP for NURTEC ODT (RIMEGEPANT SULFATE)